NIH associate director announces departure to private sector, joining anti-aging biotech
The associate director of the National Institute of Health’s Office of Legislative Policy and Analysis (OLPA) is leaving her government post to join CEO James Peyer at Cambrian BioPharma.
Adrienne Hallett made the announcement via her LinkedIn profile Wednesday morning, linking to a statement from acting NIH director Lawrence Tabak.
In her role at OLPA, Hallett oversaw and managed representing biomedical research to Congress and presidential administrations, on top of leading 120 staff in advancing policy goals, coordinating responses to oversight investigations and more.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.